{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:36:13Z","timestamp":1761708973652},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2162-3619-3-12","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T11:08:29Z","timestamp":1398251309000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expression and diagnostic values of calretinin and CK5\/6 in cholangiocarcinoma"],"prefix":"10.1186","volume":"3","author":[{"given":"Lanjing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma E","family":"Furth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy F","family":"Ziober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia A","family":"LiVolsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"key":"105_CR1","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","volume":"33","author":"T Patel","year":"2001","unstructured":"Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001, 33: 1353\u20131357. 10.1053\/jhep.2001.25087","journal-title":"Hepatology"},{"key":"105_CR2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/gut.48.6.816","volume":"48","author":"SD Taylor-Robinson","year":"2001","unstructured":"Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, Khan SA, Elliott P, Thomas HC: Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968\u20131998. Gut 2001, 48: 816\u2013820. 10.1136\/gut.48.6.816","journal-title":"Gut"},{"key":"105_CR3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/030089161209800413","volume":"98","author":"HS Ryu","year":"2012","unstructured":"Ryu HS, Lee K, Shin E, Kim SH, Jing J, Jung HY, Lee H, Jang JJ: Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma. Tumori 2012, 98: 478\u2013484.","journal-title":"Tumori"},{"key":"105_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/1471-2407-11-320","volume":"11","author":"L Fan","year":"2011","unstructured":"Fan L, He F, Liu H, Zhu J, Liu Y, Yin Z, Wang L, Guo Y, Wang Z, Yan Q, Huang G: CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 2011, 11: 320. 10.1186\/1471-2407-11-320","journal-title":"BMC Cancer"},{"key":"105_CR5","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.3748\/wjg.v19.i16.2456","volume":"19","author":"N Hongsrichan","year":"2013","unstructured":"Hongsrichan N, Rucksaken R, Chamgramol Y, Pinlaor P, Techasen A, Yongvanit P, Khuntikeo N, Pairojkul C, Pinlaor S: Annexin A1: A new immunohistological marker of cholangiocarcinoma. World J Gastroenterol 2013, 19: 2456\u20132465. 10.3748\/wjg.v19.i16.2456","journal-title":"World J Gastroenterol"},{"key":"105_CR6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/jgh.12247","volume":"28","author":"Y Sato","year":"2013","unstructured":"Sato Y, Harada K, Sasaki M, Nakanuma Y: Clinicopathological significance of S100 protein expression in cholangiocarcinoma. J Gastroenterol Hepatol 2013, 28: 1422\u20131429. 10.1111\/jgh.12247","journal-title":"J Gastroenterol Hepatol"},{"key":"105_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.7150\/jca.1.141","volume":"1","author":"L Yu","year":"2010","unstructured":"Yu L, Feng M, Kim H, Phung Y, Kleiner DE, Gores GJ, Qian M, Wang XW, Ho M: Mesothelin as a potential therapeutic target in human cholangiocarcinoma. J Cancer 2010, 1: 141\u2013149.","journal-title":"J Cancer"},{"key":"105_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2165\/11595360-000000000-00000","volume":"25","author":"M Ho","year":"2011","unstructured":"Ho M: Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin. BioDrugs 2011, 25: 275\u2013284. 10.2165\/11595360-000000000-00000","journal-title":"BioDrugs"},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3892\/ijo.2012.1662","volume":"41","author":"F Kawamata","year":"2012","unstructured":"Kawamata F, Kamachi H, Einama T, Homma S, Tahara M, Miyazaki M, Tanaka S, Kamiyama T, Nishihara H, Taketomi A, Todo S: Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer. Int J Oncol 2012, 41: 2109\u20132118.","journal-title":"Int J Oncol"},{"key":"105_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1053\/j.humpath.2003.07.002","volume":"34","author":"CC Pan","year":"2003","unstructured":"Pan CC, Chen PC, Chou TY, Chiang H: Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma. Hum Pathol 2003, 34: 1155\u20131162. 10.1053\/j.humpath.2003.07.002","journal-title":"Hum Pathol"},{"key":"105_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/modpathol.3800544","volume":"19","author":"NG Ordonez","year":"2006","unstructured":"Ordonez NG: The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study. Mod Pathol 2006, 19: 417\u2013428. 10.1038\/modpathol.3800544","journal-title":"Mod Pathol"},{"key":"105_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/modpathol.3800259","volume":"18","author":"AY Chu","year":"2005","unstructured":"Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ: Utility of D2\u201340, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 2005, 18: 105\u2013110. 10.1038\/modpathol.3800259","journal-title":"Mod Pathol"},{"key":"105_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/PAI.0b013e3181ad36ea","volume":"18","author":"R Jain","year":"2010","unstructured":"Jain R, Fischer S, Serra S, Chetty R: The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol 2010, 18: 9\u201315. 10.1097\/PAI.0b013e3181ad36ea","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"105_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/dc.20747","volume":"36","author":"RT Pu","year":"2008","unstructured":"Pu RT, Pang Y, Michael CW: Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5\/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions. Diagn Cytopathol 2008, 36: 20\u201325. 10.1002\/dc.20747","journal-title":"Diagn Cytopathol"},{"key":"105_CR15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.5858\/2005-129-1407-IDOEMA","volume":"129","author":"NG Ordonez","year":"2005","unstructured":"Ordonez NG: Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Arch Pathol Lab Med 2005, 129: 1407\u20131414.","journal-title":"Arch Pathol Lab Med"},{"key":"105_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/00000478-200308000-00001","volume":"27","author":"NG Ordonez","year":"2003","unstructured":"Ordonez NG: The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003, 27: 1031\u20131051. 10.1097\/00000478-200308000-00001","journal-title":"Am J Surg Pathol"},{"key":"105_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/modpathol.3800534","volume":"19","author":"H Yaziji","year":"2006","unstructured":"Yaziji H, Battifora H, Barry TS, Hwang HC, Bacchi CE, McIntosh MW, Kussick SJ, Gown AM: Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006, 19: 514\u2013523. 10.1038\/modpathol.3800534","journal-title":"Mod Pathol"},{"key":"105_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.humpath.2005.01.019","volume":"36","author":"NG Ordonez","year":"2005","unstructured":"Ordonez NG: D2\u201340 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 2005, 36: 372\u2013380. 10.1016\/j.humpath.2005.01.019","journal-title":"Hum Pathol"},{"key":"105_CR19","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/01.pas.0000208280.29291.34","volume":"30","author":"AV Bassarova","year":"2006","unstructured":"Bassarova AV, Nesland JM, Davidson B: D2\u201340 is not a specific marker for cells of mesothelial origin in serous effusions. Am J Surg Pathol 2006, 30: 878\u2013882. 10.1097\/01.pas.0000208280.29291.34","journal-title":"Am J Surg Pathol"},{"key":"105_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/modpathol.3880018","volume":"13","author":"PM Cury","year":"2000","unstructured":"Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG: Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5\/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 2000, 13: 107\u2013112. 10.1038\/modpathol.3880018","journal-title":"Mod Pathol"},{"key":"105_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1309\/QHCA-8594-TA7P-0DVQ","volume":"114","author":"U Brockstedt","year":"2000","unstructured":"Brockstedt U, Gulyas M, Dobra K, Dejmek A, Hjerpe A: An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 2000, 114: 203\u2013209. 10.1309\/QHCA-8594-TA7P-0DVQ","journal-title":"Am J Clin Pathol"},{"key":"105_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00000478-200302000-00002","volume":"27","author":"M Miettinen","year":"2003","unstructured":"Miettinen M, Sarlomo-Rikala M: Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol 2003, 27: 150\u2013158. 10.1097\/00000478-200302000-00002","journal-title":"Am J Surg Pathol"},{"key":"105_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/cncr.22768","volume":"111","author":"AS Onofre","year":"2007","unstructured":"Onofre AS, Pomjanski N, Buckstegge B, Bocking A: Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies. Cancer 2007, 111: 259\u2013268. 10.1002\/cncr.22768","journal-title":"Cancer"},{"key":"105_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/modpathol.2012.243","volume":"26","author":"G Krings","year":"2013","unstructured":"Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S: Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol 2013, 26: 782\u2013791. 10.1038\/modpathol.2012.243","journal-title":"Mod Pathol"},{"key":"105_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.acthis.2011.10.003","volume":"114","author":"L Zhang","year":"2012","unstructured":"Zhang L, Liu H, Sun L, Li N, Ding H, Zheng J: Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. Acta Histochem 2012, 114: 547\u2013552. 10.1016\/j.acthis.2011.10.003","journal-title":"Acta Histochem"},{"key":"105_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1309\/AJCPK1ZC9WNHCCMU","volume":"138","author":"DT Timek","year":"2012","unstructured":"Timek DT, Shi J, Liu H, Lin F: Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. Am J Clin Pathol 2012, 138: 203\u2013210. 10.1309\/AJCPK1ZC9WNHCCMU","journal-title":"Am J Clin Pathol"},{"key":"105_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1309\/59TN-EFAL-UL5W-J94M","volume":"125","author":"JY Lei","year":"2006","unstructured":"Lei JY, Bourne PA, diSant' Agnese PA, Huang J: Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver. Am J Clin Pathol 2006, 125: 519\u2013525. 10.1309\/59TN-EFAL-UL5W-J94M","journal-title":"Am J Clin Pathol"},{"key":"105_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1309\/8BM44NK626997DJJ","volume":"121","author":"CC Pan","year":"2004","unstructured":"Pan CC, Chen PC, Tsay SH, Chiang H: Cytoplasmic immunoreactivity for thyroid transcription factor-1 in hepatocellular carcinoma: a comparative immunohistochemical analysis of four commercial antibodies using a tissue array technique. Am J Clin Pathol 2004, 121: 343\u2013349. 10.1309\/8BM44NK626997DJJ","journal-title":"Am J Clin Pathol"},{"key":"105_CR29","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1309\/KKDP-MND2-W794-P9EH","volume":"118","author":"TJ Wieczorek","year":"2002","unstructured":"Wieczorek TJ, Pinkus JL, Glickman JN, Pinkus GS: Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Am J Clin Pathol 2002, 118: 911\u2013921. 10.1309\/KKDP-MND2-W794-P9EH","journal-title":"Am J Clin Pathol"},{"key":"105_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2559.2005.02331.x","volume":"48","author":"JE King","year":"2006","unstructured":"King JE, Thatcher N, Pickering CA, Hasleton PS: Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 2006, 48: 223\u2013232. 10.1111\/j.1365-2559.2005.02331.x","journal-title":"Histopathology"},{"key":"105_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00734847","volume":"401","author":"F Bonetti","year":"1983","unstructured":"Bonetti F, Chilosi M, Pisa R, Novelli P, Zamboni G, Menestrina F: Epithelial membrane antigen expression in cholangiocarcinoma. An useful immunohistochemical tool for differential diagnosis with hepatocarcinoma. Virchows Arch A Pathol Anat Histopathol 1983, 401: 307\u2013313. 10.1007\/BF00734847","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"105_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1046\/j.1440-1827.1999.00865.x","volume":"49","author":"M Tsuji","year":"1999","unstructured":"Tsuji M, Kashihara T, Terada N, Mori H: An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19\u20139, epithelial membrane antigen, and cytokeratins 18 and 19. Pathol Int 1999, 49: 310\u2013317. 10.1046\/j.1440-1827.1999.00865.x","journal-title":"Pathol Int"},{"key":"105_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4684-5754-4_32","volume":"269","author":"J Rogers","year":"1990","unstructured":"Rogers J, Khan M, Ellis J: Calretinin and other CaBPs in the nervous system. Adv Exp Med Biol 1990, 269: 195\u2013203. 10.1007\/978-1-4684-5754-4_32","journal-title":"Adv Exp Med Biol"},{"key":"105_CR34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/00000478-199609000-00001","volume":"20","author":"C Doglioni","year":"1996","unstructured":"Doglioni C, Dei Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Celio MR, Viale G: Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996, 20: 1037\u20131046. 10.1097\/00000478-199609000-00001","journal-title":"Am J Surg Pathol"},{"key":"105_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/00000478-199906000-00010","volume":"23","author":"V Gotzos","year":"1999","unstructured":"Gotzos V, Wintergerst ES, Musy JP, Spichtin HP, Genton CY: Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues. Am J Surg Pathol 1999, 23: 701\u2013711. 10.1097\/00000478-199906000-00010","journal-title":"Am J Surg Pathol"},{"key":"105_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1365-2559.2000.00940.x","volume":"37","author":"M Altini","year":"2000","unstructured":"Altini M, Coleman H, Doglioni C, Favia G, Maiorano E: Calretinin expression in ameloblastomas. Histopathology 2000, 37: 27\u201332. 10.1046\/j.1365-2559.2000.00940.x","journal-title":"Histopathology"},{"key":"105_CR37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1309\/NR6G-T872-F090-LBRW","volume":"114","author":"LM Terracciano","year":"2000","unstructured":"Terracciano LM, Mhawech P, Suess K, D'Armiento M, Lehmann FS, Jundt G, Moch H, Sauter G, Mihatsch MJ: Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol 2000, 114: 754\u2013759. 10.1309\/NR6G-T872-F090-LBRW","journal-title":"Am J Clin Pathol"},{"key":"105_CR38","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/00000478-200211000-00010","volume":"26","author":"S Movahedi-Lankarani","year":"2002","unstructured":"Movahedi-Lankarani S, Kurman RJ: Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol 2002, 26: 1477\u20131483. 10.1097\/00000478-200211000-00010","journal-title":"Am J Surg Pathol"},{"key":"105_CR39","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/01.MP.0000073133.79591.A1","volume":"16","author":"MT Deavers","year":"2003","unstructured":"Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG: Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 2003, 16: 584\u2013590. 10.1097\/01.MP.0000073133.79591.A1","journal-title":"Mod Pathol"},{"key":"105_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.humpath.2004.11.011","volume":"36","author":"HP Cathro","year":"2005","unstructured":"Cathro HP, Stoler MH: The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol 2005, 36: 195\u2013201. 10.1016\/j.humpath.2004.11.011","journal-title":"Hum Pathol"},{"key":"105_CR41","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1097\/PAS.0b013e3182363b78","volume":"35","author":"JC Wooff","year":"2011","unstructured":"Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ: Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol 2011, 35: 1786\u20131793. 10.1097\/PAS.0b013e3182363b78","journal-title":"Am J Surg Pathol"},{"key":"105_CR42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/01.MP.0000073134.60541.E8","volume":"16","author":"PJ Zhang","year":"2003","unstructured":"Zhang PJ, Genega EM, Tomaszewski JE, Pasha TL, LiVolsi VA: The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod Pathol 2003, 16: 591\u2013597. 10.1097\/01.MP.0000073134.60541.E8","journal-title":"Mod Pathol"},{"key":"105_CR43","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00000478-200105000-00007","volume":"25","author":"M Miettinen","year":"2001","unstructured":"Miettinen M, Limon J, Niezabitowski A, Lasota J: Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol 2001, 25: 610\u2013617. 10.1097\/00000478-200105000-00007","journal-title":"Am J Surg Pathol"},{"key":"105_CR44","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1365-2559.2011.04031.x","volume":"59","author":"G Powell","year":"2011","unstructured":"Powell G, Roche H, Roche WR: Expression of calretinin by breast carcinoma and the potential for misdiagnosis of mesothelioma. Histopathology 2011, 59: 950\u2013956. 10.1111\/j.1365-2559.2011.04031.x","journal-title":"Histopathology"},{"key":"105_CR45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/DAD.0b013e31823aded5","volume":"34","author":"E Gonzalez-Guerra","year":"2012","unstructured":"Gonzalez-Guerra E, Kutzner H, Rutten A, Requena L: Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations. Am J Dermatopathol 2012, 34: 491\u2013505. 10.1097\/DAD.0b013e31823aded5","journal-title":"Am J Dermatopathol"},{"key":"105_CR46","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1053\/S0046-8177(03)00339-3","volume":"34","author":"A Lugli","year":"2003","unstructured":"Lugli A, Forster Y, Haas P, Nocito A, Bucher C, Bissig H, Mirlacher M, Storz M, Mihatsch MJ, Sauter G: Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol 2003, 34: 994\u20131000. 10.1053\/S0046-8177(03)00339-3","journal-title":"Hum Pathol"},{"key":"105_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1159\/000339586","volume":"56","author":"TS Hyun","year":"2012","unstructured":"Hyun TS, Barnes M, Tabatabai ZL: The diagnostic utility of D2\u201340, calretinin, CK5\/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology. Acta Cytol 2012, 56: 527\u2013532. 10.1159\/000339586","journal-title":"Acta Cytol"},{"key":"105_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1097\/PAS.0b013e31825d5371","volume":"36","author":"T Mohammad","year":"2012","unstructured":"Mohammad T, Garratt J, Torlakovic E, Gilks B, Churg A: Utility of a CEA, CD15, calretinin, and CK5\/6 panel for distinguishing between mesotheliomas and pulmonary adenocarcinomas in clinical practice. Am J Surg Pathol 2012, 36: 1503\u20131508. 10.1097\/PAS.0b013e31825d5371","journal-title":"Am J Surg Pathol"},{"key":"105_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1309\/21TW-2NDG-JRK4-PFJX","volume":"116","author":"O Kaufmann","year":"2001","unstructured":"Kaufmann O, Fietze E, Mengs J, Dietel M: Value of p63 and cytokeratin 5\/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001, 116: 823\u2013830. 10.1309\/21TW-2NDG-JRK4-PFJX","journal-title":"Am J Clin Pathol"},{"key":"105_CR50","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/modpathol.2009.90","volume":"22","author":"AR Sangoi","year":"2009","unstructured":"Sangoi AR, McKenney JK, Schwartz EJ, Rouse RV, Longacre TA: Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases. Mod Pathol 2009, 22: 1228\u20131235. 10.1038\/modpathol.2009.90","journal-title":"Mod Pathol"},{"key":"105_CR51","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/00000478-199810000-00006","volume":"22","author":"NG Ordonez","year":"1998","unstructured":"Ordonez NG: Value of cytokeratin 5\/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 1998, 22: 1215\u20131221. 10.1097\/00000478-199810000-00006","journal-title":"Am J Surg Pathol"},{"key":"105_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1046\/j.1365-2559.1997.2150833.x","volume":"31","author":"J Clover","year":"1997","unstructured":"Clover J, Oates J, Edwards C: Anti-cytokeratin 5\/6: a positive marker for epithelioid mesothelioma. Histopathology 1997, 31: 140\u2013143. 10.1046\/j.1365-2559.1997.2150833.x","journal-title":"Histopathology"},{"key":"105_CR53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/modpathol.3880332","volume":"14","author":"DE Kardon","year":"2001","unstructured":"Kardon DE, Thompson LD, Przygodzki RM, Heffess CS: Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Mod Pathol 2001, 14: 443\u2013451. 10.1038\/modpathol.3880332","journal-title":"Mod Pathol"},{"key":"105_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2559.1993.tb01182.x","volume":"23","author":"Z Suo","year":"1993","unstructured":"Suo Z, Holm R, Nesland JM: Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours. Histopathology 1993, 23: 45\u201354. 10.1111\/j.1365-2559.1993.tb01182.x","journal-title":"Histopathology"},{"key":"105_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/dc.20975","volume":"37","author":"S Khayyata","year":"2009","unstructured":"Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, Gupta P, Baloch Z: Value of P63 and CK5\/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Diagn Cytopathol 2009, 37: 178\u2013183. 10.1002\/dc.20975","journal-title":"Diagn Cytopathol"},{"key":"105_CR56","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/modpathol.2011.92","volume":"24","author":"N Rekhtman","year":"2011","unstructured":"Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL: Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Mod Pathol 2011, 24: 1348\u20131359. 10.1038\/modpathol.2011.92","journal-title":"Mod Pathol"},{"key":"105_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/modpathol.3880483","volume":"15","author":"PG Chu","year":"2002","unstructured":"Chu PG, Weiss LM: Expression of cytokeratin 5\/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol 2002, 15: 6\u201310. 10.1038\/modpathol.3880483","journal-title":"Mod Pathol"},{"key":"105_CR58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/01.pai.0000213148.62525.9a","volume":"15","author":"AM Marchevsky","year":"2007","unstructured":"Marchevsky AM, Wick MR: Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma. Appl Immunohistochem Mol Morphol 2007, 15: 140\u2013144. 10.1097\/01.pai.0000213148.62525.9a","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"105_CR59","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1242\/dev.082396","volume":"139","author":"NI Winters","year":"2012","unstructured":"Winters NI, Thomason RT, Bader DM: Identification of a novel developmental mechanism in the generation of mesothelia. Development 2012, 139: 2926\u20132934. 10.1242\/dev.082396","journal-title":"Development"},{"key":"105_CR60","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/ncb2610","volume":"14","author":"Y Rinkevich","year":"2012","unstructured":"Rinkevich Y, Mori T, Sahoo D, Xu PX, Bermingham JR Jr, Weissman IL: Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature. Nat Cell Biol 2012, 14: 1251\u20131260. 10.1038\/ncb2610","journal-title":"Nat Cell Biol"},{"key":"105_CR61","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/jb\/mvr001","volume":"149","author":"M Tanaka","year":"2011","unstructured":"Tanaka M, Itoh T, Tanimizu N, Miyajima A: Liver stem\/progenitor cells: their characteristics and regulatory mechanisms. J Biochem 2011, 149: 231\u2013239. 10.1093\/jb\/mvr001","journal-title":"J Biochem"},{"key":"105_CR62","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.biocel.2003.11.002","volume":"36","author":"SE Herrick","year":"2004","unstructured":"Herrick SE, Mutsaers SE: Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol 2004, 36: 621\u2013642. 10.1016\/j.biocel.2003.11.002","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-3-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:27:53Z","timestamp":1648873673000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/2162-3619-3-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1186\/2162-3619-3-12","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]},"assertion":[{"value":"24 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}